<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">Interestingly, a different level of benefit was noted after deep brain stimulation surgery in 
 <italic>LRRK2</italic>-associated PD. The outcome was better in patients with the most common 
 <italic>LRRK2</italic> mutation, p.G2019S, compared to the poor response seen in patients with the rarer p.R1441G mutation. However, overall numbers remain small. The overall benefit was compromised by the rapid progression of cognitive and neuropsychiatric symptoms [
 <xref ref-type="bibr" rid="CR46">46</xref>].
</p>
